4//SEC Filing
Riebe Michael T 4
Accession 0001567619-20-020723
CIK 0001692830other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 6:06 PM ET
Size
5.4 KB
Accession
0001567619-20-020723
Insider Transaction Report
Form 4
Riebe Michael T
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-03+20,000→ 20,000 totalExercise: $4.60Exp: 2030-12-03→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting.
Documents
Issuer
Satsuma Pharmaceuticals, Inc.
CIK 0001692830
Entity typeother
Related Parties
1- filerCIK 0001787242
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 6:06 PM ET
- Size
- 5.4 KB